Donald L. Hagan, LLC Merck & Co., Inc. Transaction History

Donald L. Hagan, LLC

$183 Million
Q3 2024

A detailed history of Donald L. Hagan, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Donald L. Hagan, LLC holds 8,784 shares of MRK stock, worth $871,197. This represents 0.55% of its overall portfolio holdings.

Number of Shares

8,784

Previous 8,361 5.06%

Holding current value

$871,197

Previous $1.04 Million 3.67%

% of portfolio

0.55%

Previous 0.58%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$111.15 - $128.97 $47,016 - $54,554	423 Added 5.06%	8,784 $997,000
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $63,633 - $68,341	-514 Reduced 5.79%	8,361 $1.04 Million
Q1 2024 Apr 19, 2024	SELL	$113.24 - $131.95 $22,195 - $25,862	-196 Reduced 2.16%	8,875 $1.17 Million
Q4 2023 Jan 19, 2024	BUY	$100.18 - $109.02 $3,907 - $4,251	39 Added 0.43%	9,071 $988,000
Q3 2023 Oct 11, 2023	SELL	$102.95 - $114.33 $126,010 - $139,939	-1,224 Reduced 11.93%	9,032 $929,000
Q2 2023 Jul 17, 2023	SELL	$108.61 - $118.38 $40,728 - $44,392	-375 Reduced 3.53%	10,256 $1.18 Million
Q1 2023 Apr 18, 2023	SELL	$102.94 - $114.86 $419,480 - $468,054	-4,075 Reduced 27.71%	10,631 $1.13 Million
Q4 2022 Jan 17, 2023	SELL	$87.44 - $112.11 $10,667 - $13,677	-122 Reduced 0.82%	14,706 $0
Q3 2022 Oct 12, 2022	BUY	$84.53 - $94.96 $20,540 - $23,075	243 Added 1.67%	14,828 $1.28 Million
Q2 2022 Jul 20, 2022	SELL	$83.49 - $94.64 $8,933 - $10,126	-107 Reduced 0.73%	14,585 $1.33 Million
Q1 2022 Apr 18, 2022	BUY	$73.51 - $82.4 $1.08 Million - $1.21 Million	14,692 New	14,692 $1.21 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donald L. Hagan, LLC with notifications on news.

Account

Donald L. Hagan, LLC Merck & Co., Inc. Transaction History